wayground logo

Free Printable Worksheets

NEW

Font size

S
M
L
XL
Worksheets

NSTEMI and NSTE-ACS Quiz

Total questions: 59

Worksheet time: 30mins

Name
Class
Date
1.

What does NSTEMI stand for in the context of acute coronary syndromes?

a)

Non-ST-segment elevation myocardial infarction

b)

Non-specific transient elevation myocardial infarction

c)

Non-sustained tachycardia event myocardial infarction

d)

Non-symptomatic thrombotic event myocardial infarction

2.

Which of the following is NOT a typical feature used in the diagnosis of NSTEMI-ACS?

a)

Occurrence at rest or with minimal exertion, lasting >10 minutes

b)

Relatively recent onset (within the prior 2 weeks)

c)

Crescendo pattern of chest discomfort

d)

Presence of a heart murmur

3.

According to the text, which group of patients is classified as having non-ST-segment elevation acute coronary syndrome (NSTE-ACS)?

a)

Patients with acute myocardial infarction without ST-segment elevation and those with unstable angina

b)

Patients with ST-segment elevation myocardial infarction only

c)

Patients with chronic stable angina

d)

Patients with heart failure but no coronary artery disease

4.

What is the main reason for the increasing incidence of NSTEMI compared to STEMI?

a)

Greater use of aspirin, statins, and less smoking

b)

Increased rates of diabetes and obesity

c)

Improved surgical techniques

d)

More frequent use of beta-blockers

5.

Which of the following best describes the pathophysiology of NSTE-ACS?

a)

Imbalance between myocardial oxygen supply and demand, often due to plaque rupture or erosion

b)

Sudden complete occlusion of a coronary artery by a thrombus

c)

Chronic narrowing of coronary arteries without acute events

d)

Viral infection of the myocardium

6.

According to angiographic studies, what percentage of patients with NSTE-ACS have three-vessel coronary artery disease?

a)

35%

b)

10%

c)

20%

d)

15%

7.

Why is the proportion of NSTEMI increasing relative to STEMI?

a)

Because of the wider use of highly sensitive troponin (hsTn) assays

b)

Because of increased rates of hypertension

c)

Because of improved diet and exercise

d)

Because of more frequent use of angiography

8.

Which of the following is a possible cause of myocardial oxygen demand increase in NSTE-ACS without thrombosis?

a)

Epicardial or microvascular spasm

b)

Viral myocarditis

c)

Congenital heart defect

d)

Aortic stenosis

9.

Which of the following is NOT a parameter used in the initial assessment of patients with suspected acute coronary syndromes?

a)

Clinical presentation (symptoms, vital signs)

b)

12-lead electrocardiogram (ECG)

c)

Circulating troponin levels

d)

Blood glucose measurement

10.

What does NSTEMI stand for in the context of acute coronary syndromes?

a)

Non-ST-segment elevation myocardial infarction

b)

Non-specific transient myocardial injury

c)

New-onset stable tachycardia event

d)

Non-sustained tachyarrhythmia episode

11.

Which of the following is a typical location for chest discomfort in acute coronary syndromes?

a)

Lower abdomen

b)

Substernal region radiating to the left arm, left shoulder, and/or neck and jaw

c)

Right lower leg

d)

Upper back only

12.

Which of the following is a characteristic of a ruptured plaque in human coronary arteries?

a)

Thin fibrous cap and many macrophages

b)

Many smooth muscle cells and platelet-rich thrombus

c)

Little or no lipid core and neutrophils

d)

Glycosaminoglycan-rich matrix

13.

According to the TIMI Risk Score for NSTE-ACS, which of the following is NOT considered a risk marker?

a)

Age ≥65 years

b)

Known CAD (>50% stenosis)

c)

History of asthma

d)

ST deviation ≥0.5mm on presenting ECG

14.

Which of the following best describes the role of cardiac biomarkers in the diagnosis of NSTE-ACS?

a)

They are used to measure blood pressure

b)

They indicate myocardial necrosis through elevated troponin levels

c)

They are only useful for diagnosing arrhythmias

d)

They are not relevant in acute coronary syndromes

15.

A patient presents with chest discomfort, ST-segment depression on ECG, and elevated troponin. What is the most likely diagnosis?

a)

Non-cardiac chest pain

b)

Unstable angina (UA)

c)

Non-ST-segment elevation myocardial infarction (NSTEMI)

d)

ST-segment elevation myocardial infarction (STEMI)

16.

Which of the following statements about electrocardiogram (ECG) changes in NSTE-ACS is correct?

a)

ST-segment elevation is always present

b)

ST-segment depression may be transient or persistent

c)

ECG changes are not useful in diagnosis

d)

Only T-wave inversion is seen

17.

Which of the following is a reason for the elevation of cardiac troponin values as a result of myocardial injury related to acute myocardial infarction?

a)

Atherosclerotic plaque disruption or erosion with thrombosis

b)

Coronary artery spasm

c)

Sepsis

d)

Defibrillator shocks

18.

Which of the following is NOT listed as a reduced myocardial perfusion cause of myocardial injury?

a)

Coronary artery embolism

b)

Sustained tachyarrhythmia

c)

Coronary artery dissection

d)

Severe anemia

19.

Which systemic condition is mentioned as a cause of myocardial injury?

a)

Sepsis

b)

Coronary artery spasm

c)

Heart failure

d)

Takotsubo syndrome

20.

What is the primary purpose of coronary computed tomographic angiography (CCTA) in the context of acute coronary syndromes?

a)

To improve the accuracy and speed of diagnostic evaluation

b)

To treat myocardial infarction

c)

To monitor heart rate

d)

To administer medication

21.

Patients with documented NSTE-ACS exhibit a wide spectrum of early (30 days) risk of death. What is the approximate range of this risk?

a)

1 to 10%

b)

10 to 20%

c)

5 to 15%

d)

15 to 25%

22.

Which medication is recommended for patients with persistent symptoms or ECG signs of ischemia after initial treatment with full-dose nitrates and beta blockers?

a)

Heart rate–slowing calcium channel blockers

b)

Aspirin

c)

Statins

d)

ACE inhibitors

23.

Why are beta blockers recommended in the treatment of NSTE-ACS?

a)

They reduce myocardial oxygen demands

b)

They increase heart rate

c)

They cause vasoconstriction

d)

They increase blood pressure

24.

A patient with NSTE-ACS is experiencing ischemic discomfort. What is the recommended initial dose of sublingual or buccal nitroglycerin?

a)

0.3–0.6 mg

b)

5–10 μg/min

c)

200 μg/min

d)

50–60 beats/min

25.

Which of the following is a contraindication to the use of nitrates in the treatment of NSTE-ACS?

a)

Hypotension or recent use of a phosphodiesterase type 5 (PDE-5) inhibitor

b)

Sepsis

c)

Chronic kidney disease

d)

Coronary artery spasm

26.

What is the main goal of anti-ischemic treatment in patients with NSTE-ACS?

a)

To provide relief of pain and discomfort

b)

To increase heart rate

c)

To induce arrhythmias

d)

To cause myocardial infarction

27.

Which of the following is the first step in evaluating a patient with acute chest pain according to the HEART pathway?

a)

Administering antiplatelet therapy

b)

Performing an ECG

c)

Measuring initial troponin

d)

Calculating the HEART score

28.

According to the HEART pathway, what should be done if a patient with acute chest pain has a nonischemic ECG and a HEART score of 0–3?

a)

Early discharge

b)

Cardiology consult and admission

c)

Observation or admission

d)

Immediate PCI

29.

Which of the following is a recommended initial antiplatelet therapy for patients with acute chest pain?

a)

Statins

b)

ACE inhibitors

c)

Clopidogrel with a dose of at least 162 mg of aspirin

d)

Beta-blockers

30.

What is the main goal of early administration of statins in patients with acute coronary syndrome (ACS)?

a)

To increase blood pressure

b)

To reduce periprocedural MI and recurrences of ACS

c)

To prevent arrhythmias

d)

To increase LDL-C levels

31.

A patient with NSTE-ACS is at high risk for bleeding. Which P2Y12 inhibitor is recommended due to its lower risk of major bleeding?

a)

Prasugrel

b)

Ticagrelor

c)

Clopidogrel

d)

Aspirin

32.

Which of the following statements best describes the difference between prasugrel and clopidogrel in the context of ACS treatment?

a)

Prasugrel is associated with a lower risk of bleeding than clopidogrel.

b)

Prasugrel has a more rapid onset and higher level of irreversible platelet inhibition than clopidogrel.

c)

Clopidogrel is only used in STEMI, not NSTE-ACS.

d)

Prasugrel is not approved for use with PCI.

33.

Which of the following is a recommendation for the use of nitrates in patients with Non-ST-segment elevation acute coronary syndrome (NSTE-ACS)?

a)

Use sublingual or intravenous nitrates to relieve angina

b)

Initiate early for ischemic symptoms in all patients

c)

Use only in patients with bradycardia

d)

Avoid in all patients with hypertension

34.

Which condition is a contraindication for the use of beta blockers in NSTE-ACS patients?

a)

PR interval >0.24 s

b)

Systolic pressure >90 mmHg

c)

Heart rate >100 beats/min

d)

Recent use of a PDE-5 inhibitor

35.

When should calcium channel blockers be considered in patients with NSTE-ACS?

a)

In patients with vasospastic angina

b)

In all patients with heart failure

c)

Only in patients with bradycardia

d)

In patients with high potassium levels

36.

Which of the following is a reason to avoid morphine or other narcotic analgesics in NSTE-ACS?

a)

Respiratory depression

b)

Systolic pressure >90 mmHg

c)

Pulmonary edema

d)

High heart rate

37.

Which oral antiplatelet therapy is contraindicated in patients with prior stroke or transient ischemic attack?

a)

Prasugrel

b)

Clopidogrel

c)

Aspirin

d)

Ticagrelor

38.

A patient with NSTE-ACS who develops a new coronary event while receiving clopidogrel and aspirin should be considered for which additional therapy?

a)

P2Y12 blocker (prasugrel or ticagrelor)

b)

Beta blocker

c)

Calcium channel blocker

d)

Morphine

39.

Which intravenous antiplatelet agent is administered as a 30 μg/kg bolus followed by 4 μg/kg/min infusion for 2 hours during PCI?

a)

Cangrelor

b)

Eptifibatide

c)

Tirofiban

d)

Bivalirudin

40.

Which of the following is a correct maintenance dose for Apixaban in patients with atrial fibrillation after PCI?

a)

5 mg twice daily

b)

10 mg once daily

c)

2.5 mg once daily

d)

15 mg twice daily

41.

What is the main risk associated with long-term dual antiplatelet therapy (DAPT) in patients with NSTE-ACS?

a)

Increased risk of bleeding

b)

Increased risk of hypertension

c)

Increased risk of bradycardia

d)

Increased risk of heart failure

42.

Which of the following is a reason for the failure of routine early initiation of glycoprotein IIb/IIIa inhibitor therapy in NSTE-ACS patients?

a)

Increased risk of major bleeding

b)

Lack of efficacy in reducing angina

c)

Increased risk of hypertension

d)

Increased risk of bradycardia

43.

Which of the following is considered the mainstay of therapy among parenteral options available for anticoagulation in NSTE-ACS?

a)

Low-molecular-weight heparin (LMWH) enoxaparin

b)

Unfractionated heparin (UFH)

c)

Bivalirudin

d)

Fondaparinux

44.

Which anticoagulant is associated with a lower risk of major bleeding compared to enoxaparin but requires supplemental UFH to prevent catheter thrombosis?

a)

Bivalirudin

b)

Fondaparinux

c)

Unfractionated heparin (UFH)

d)

Low-molecular-weight heparin (LMWH)

45.

Why is early invasive strategy recommended in patients with NSTE-ACS who have a high risk of recurrent cardiac events?

a)

It reduces the risk of excessive bleeding

b)

It is less expensive than conservative management

c)

It has been shown to be superior in reducing recurrent cardiac events

d)

It eliminates the need for antiplatelet therapy

46.

What is the most important adverse effect of all antithrombotic agents?

a)

Hypertension

b)

Excessive bleeding

c)

Bradycardia

d)

Hyperglycemia

47.

In the context of NSTE-ACS, what does an invasive strategy typically involve?

a)

Immediate administration of oral anticoagulants only

b)

Early coronary angiography and possible revascularization within 48 hours

c)

Delaying all interventions until symptoms resolve

d)

Use of only non-invasive testing

48.

According to the risk stratification flowchart for NSTE-ACS, what is the recommended action for a patient classified as 'very high' risk?

a)

Immediate transfer to PCI center

b)

Non-invasive testing if appropriate

c)

Early invasive strategy within 24 hours

d)

Transfer optional

49.

Which of the following is NOT a criterion for considering a patient at high risk in the context of NSTE-ACS?

a)

Multiple clinical risk factors

b)

ST-segment deviation

c)

Positive biomarkers

d)

Absence of chest pain

50.

Which of the following is emphasized as a key aspect of long-term management for patients with NSTEMI-ACS?

a)

Immediate surgical intervention

b)

Risk factor modification

c)

Avoidance of all medications

d)

Complete bed rest

51.

According to the text, what is the recommended initial antiplatelet regimen for patients with NSTEMI-ACS?

a)

Aspirin and a P2Y₁₂ inhibitor for 12 months

b)

Beta blockers and statins for 6 months

c)

Nitrates and calcium channel blockers for 3 months

d)

Warfarin and aspirin for 24 months

52.

Which of the following statements best describes Prinzmetal’s variant angina (PVA)?

a)

It is caused by atherosclerotic plaque rupture

b)

It is a syndrome of severe ischemic pain due to coronary artery spasm

c)

It is always associated with myocardial infarction

d)

It is only found in elderly patients

53.

What is the main therapeutic approach for Prinzmetal’s variant angina?

a)

Beta blockers and diuretics

b)

Nitrates and calcium channel blockers

c)

Statins and ACE inhibitors

d)

Antiplatelet therapy alone

54.

Which of the following is a reason why patients with PVA may have a lower incidence of cardiac death compared to those with atherosclerotic obstructive lesions?

a)

They are always treated with surgery

b)

They have no risk of arrhythmias

c)

They often have no or mild fixed coronary obstruction

d)

They are not given any medications

55.

Based on the text, what is a major challenge in reducing the burden of ischemic heart disease in low- and middle-income countries?

a)

Lack of effective medications

b)

Socio-economic and healthcare system limitations

c)

Overuse of advanced technology

d)

Excessive physical activity

56.

A patient with NSTEMI-ACS and diabetes is being considered for long-term therapy. According to the text, which additional class of drugs may be recommended for such patients?

a)

SGLT-2 inhibitors or GLP-1 receptor agonists

b)

Thiazide diuretics

c)

Anticoagulants only

d)

Opioid analgesics

57.

Why is the diagnosis of Prinzmetal’s variant angina (PVA) sometimes challenging?

a)

It always presents with classic symptoms

b)

Coronary angiography always shows severe obstruction

c)

Clinical examination is usually unremarkable in the absence of ischemia

d)

It is only seen in elderly patients

58.

Which of the following best describes the prognosis for patients with PVA after an acute episode?

a)

All patients die within 6 months

b)

Survival at 5 years is excellent, but some may develop arrhythmias or cardiac events

c)

No risk of future cardiac events

d)

All patients require heart transplantation

59.

What is a key factor in the global increase in coronary risk factors, as discussed in the text?

a)

Decreased urbanization

b)

Improved childhood nutrition

c)

Urbanization and reduction of physical labor

d)

Universal access to healthcare